Skip Navigation
Skip to contents

SSBH 2026

Official SNS Channel
instagram X
Today : 2026.03.16

D -94

Day 3
June 20(Sat)
09:00-10:00
Oral Presentation 3
Room 1
Day 3
June 20(Sat)
10:15-11:00
Plenary Lecture 3
Room 1
We are privileged to welcome Professor Dennis M. Black from the University of California, San Francisco (UCSF), as a Plenary Speaker for SSBH 2026. A towering figure in the field of osteoporosis clinical trials, Professor Black has been the lead investigator for several landmark studies that have shaped current treatment guidelines. In this lecture, he will present the transformative findings of the SABRE (Study to Advance BMD as a Regulatory Endpoint) Project. The SABRE project is a monumental effort that addressed a decades-long challenge in drug development: the necessity of long-term fracture trials for new drug approval. By analyzing data from over 160,000 participants across dozens of clinical trials, Professor Black and his team established Bone Mineral Density (BMD) change as a validated surrogate endpoint for fracture risk reduction. This breakthrough led to the historic 2025 FDA qualification of BMD as a primary regulatory endpoint, significantly accelerating the pathway for future osteoporosis therapies. In this session, Professor Black will detail the rigorous statistical framework of SABRE and discuss how these results will catalyze the development of next-generation bone-forming agents and combination therapies.
10:15-11:00 The Coming Cascade of New Osteoporosis Treatments:
Implications of FDA Qualification of BMD Change to Replace Fracture Risk as the Trial Endpoint for New Osteoporosis Therapies
Dennis M Black (University of California, San Francisco, USA)
Day 3
June 20(Sat)
11:15-12:30
Symposium 4. Optimizing Treatment Strategies with Anabolic Agents
Room 1
11:15-11:40 The Anabolic Trio: Comparative Review of Teriparatide, Abaloparatide, and Romosozumab Kosuke Ebina (Osaka University, Japan)
11:40-12:05 Cardiovascular Safety of Anabolics: Evidence, Controversies, and Real-World Implications Seong Hee Ahn (Inha University, Korea)
12:05-12:30 Cardiovascular Safety of Anabolics: Evidence, Controversies, and Real-World Implications Namki Hong (Yonsei University, Korea)
Day 3
June 20(Sat)
12:30-12:45
Luncheon Symposium 3
Room 1
Day 3
June 20(Sat)
13:30-14:40
Oral Presentation 5
Room 1
Day 3
June 20(Sat)
14:55-16:10
Symposium 6. Transforming Bone Health with Artificial Intelligence and Deep Learning
Room 1
14:55-15:20 Precision Medicine in Osteoporosis: Applying AI in Predicting Treatment Response Kyoung Min Kim (Yonsei University, Korea)
15:20-15:45 Integrating Muscle and Bone Metrics for Improved Fracture Risk Assessment Sung Hye Kong (Seoul National University, Korea)
15:45-16:10 Screening for Osteoporosis and Skeletal Muscle Loss Using CT Images and X-Rays Keisuke Uemura (Osaka University, Japan)
Day 3
June 20(Sat)
09:00-10:10
Oral Presentation 4
Room 2
Day 3
June 20(Sat)
11:15-12:30
Symposium 5. Next-Generation Musculoskeletal Biology
Room 2
Musculoskeletal biology is rapidly evolving toward an integrated understanding of bone, cartilage, muscle, and their microenvironments, driven by advances in systems biology, organoid models, microphysiological platforms, and spatial omics technologies. This symposium aims to explore the frontiers of next-generation musculoskeletal biology research by showcasing innovative model systems and advanced analytical approaches that are redefining our understanding of skeletal health and disease. Professor Ng Shyh-Chang (Chinese Academy of Sciences, China) has contributed significantly to the conceptual and technological development of next-generation musculoskeletal biology. His lecture will introduce skeletal muscle organoid models to study exercise and insulin resistance, highlighting how organoid-based systems can provide new insights into muscle metabolism and the broader landscape of musculoskeletal biology. Professor Junmin Lee (POSTECH, Korea) will introduce Bone-on-a-Chip models and organoid systems that recapitulate osteochondral tissue interfaces, discussing how these platforms can revolutionize bone regeneration research. He will present strategies that combine microfluidic technology with three-dimensional tissue engineering to precisely recreate the skeletal microenvironment in vitro. Professor Lutian Yao (The First Hospital of China Medical University, China) utilizes spatial transcriptomics to investigate the spatial organization of cellular microenvironments and regenerative processes within bone tissue. This talk will present recent advances in mapping cellular niches in bone and their implications for understanding skeletal regeneration. Together, this session will highlight how diverse next-generation technologies are reshaping musculoskeletal biology and providing critical links between fundamental research and clinical applications. We warmly invite basic researchers and clinicians to join this insightful and forward-looking discussion.
11:15-11:40 Skeletal Muscle Organoids to Model Exercise and Insulin Resistance Ng Shyh-Chang (Chinese Academy of Sciences, China)
11:40-12:05 Bone-on-a-Chip and Osteochondral Tissue Models: Microphysiological Platforms for Skeletal Interfaces Junmin Lee (POSTECH, Korea)
12:05-12:30 Spatial Transcriptomics in Bone: Mapping Cellular Niches and Regeneration Lutian Yao (The First Hospital of China Medical University, China)
Day 3
June 20(Sat)
12:30-12:45
Luncheon Symposium 4
Room 2
Day 3
June 20(Sat)
13:30-14:40
Oral Presentation 6
Room 2
Day 3
June 20(Sat)
14:55-16:10
Symposium 7. Space Biology
Room 2
As humanity extends its reach toward the Moon and Mars, understanding the biological impact of the space environment has become a critical priority. This symposium explores the cutting-edge research in Space Biology, focusing on how microgravity accelerates physiological changes in the musculoskeletal and neuromuscular systems. We will discuss innovative drug testing on the ISS, the fundamental biological shifts in model organisms, and the systemic signaling mechanisms connecting musculoskeletal health to other organ systems. 1. Professor Junsoo Park presents groundbreaking research conducted aboard the International Space Station (ISS). This study evaluates the efficacy of new drug candidates designed to combat muscle atrophy, utilizing the extreme environment of space to accelerate and observe muscle loss in ways impossible on Earth. 2. Dr. Atsushi Higashitani explores how the lack of physical "touch" or tactile resistance in microgravity affects the neuromuscular system. Using C. elegans as a model organism, this talk reveals how reduced physical stimuli lead to functional decline, providing clues into the mechanical sensors of living cells. 3. Professor Hyeonwoo Kim delves into the complex signaling networks altered by microgravity. His talk focuses on how musculoskeletal deterioration is not an isolated event but a systemic issue, examining the intricate "crosstalk" between organs that maintains physiological homeostasis under the stress of spaceflight.
14:55-15:20 Testing Novel Muscle Atrophy Drug Candidates on the International Space Station Junsoo Park (Yonsei University, Korea)
15:20-15:45 The Reduction in Physical Tactile Stimuli Due to Microgravity in Space Has a Significant Impact on Neuromuscular Function in C. elegans Atsushi Higashitani (Tohoku University, Japan)
15:45-16:10 Accelerated Degeneration of Organ Function Associated with Spaceflight: Mechanistic Insights and Protective Strategies Hyeonwoo Kim (KAIST, Korea)
Day 3
June 20(Sat)
09:00-10:10
Working Group 3. Vitamin D Working Group
Precision medicine and New perspective Room 3
Day 3
June 20(Sat)
11:15-12:30
Working Group 4. Academia-Industrial Network Working Group
Innovative Wearable and AI Solutions for Post-Fracture Care, Home Rehabilitation, and FLS: Industry-Academia Collaboration Symposium Room 3
Day 3
June 20(Sat)
13:30-14:40
Meet the Expert 3
Room 3
13:30-14:20 Treatment Strategies to Maximize Benefits vs High Risks of Atypical Femur Fractures in Asian Patients Dennis M Black (University of California, San Francisco, USA)
Day 3
June 20(Sat)
14:55-16:10
Working Group 5. PTH Working Group
Parathyroid Hormone in 2026: From Receptor Kinetics to Skeletal Precision Room 3

Korean Society for Bone and Mineral Research (KSBMR)

#1001, Hyundai Kirim Bldg, 42, Seocho-daero 78-gil, Seocho-gu, Seoul, 06626, Korea

T. +82-2-3473-2230~1 | E. ksbmr@ksbmr.org

Business Registration Number: 106-82-62498

Name of Representative: Sang Wan Kim

SSBH 2026 Secretariat (PLANDO)

#615, 220, Gonghang-daero, Gangseo-gu, Seoul, 07806, Republic of Korea

T. +82-2-6734-1007, 1016 | E. info@ssbh.co.kr